M Menza

Summary

Affiliation: New Jersey
Country: USA

Publications

  1. ncbi The role of inflammatory cytokines in cognition and other non-motor symptoms of Parkinson's disease
    Matthew Menza
    Psychiatry and Neurology, Robert Wood Johnson Medical School, D207A, 671 Hoes Lane, Piscataway, NJ 08854, USA
    Psychosomatics 51:474-9. 2010
  2. ncbi A controlled trial of antidepressants in patients with Parkinson disease and depression
    M Menza
    Department of Psychiatry, Robert Wood Johnson Medical School, UMDNJ University Behavioral Health Care, Piscataway, NJ 08854, USA
    Neurology 72:886-92. 2009
  3. ncbi Managing atypical antipsychotic-associated weight gain: 12-month data on a multimodal weight control program
    Matthew Menza
    Department of Psychiatry, Robert Wood Johnson Medical School, D207A, 671 Hoes Lane, Piscataway, NJ 08854, USA
    J Clin Psychiatry 65:471-7. 2004
  4. ncbi The impact of treatment of depression on quality of life, disability and relapse in patients with Parkinson's disease
    Matthew Menza
    Department of Psychiatry, Robert Wood Johnson Medical School, Piscataway, New Jersey 08854, USA
    Mov Disord 24:1325-32. 2009
  5. ncbi Treatment of depression in Parkinson's disease
    Matthew Menza
    Department of Psychiatry, Robert Wood Johnson Medical School, D207A, 671 Hoes Lane, Piscataway, NJ 08854, USA
    Curr Psychiatry Rep 8:234-40. 2006
  6. ncbi Residual symptoms in depression: can treatment be symptom-specific?
    Matthew Menza
    Department of Psychiatry, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, Piscataway 08854, USA
    J Clin Psychiatry 64:516-23. 2003
  7. ncbi Sleep disturbances in Parkinson's disease
    Matthew Menza
    Department of Psychiatry, Robert Wood Johnson Medical School, Piscataway, New Jersey 08854, USA
    Mov Disord 25:S117-22. 2010
  8. ncbi Treatment of somatization disorder with nefazodone: a prospective, open-label study
    M Menza
    Department of Psychiatry, Robert Wood Johnson Medical School, Piscataway, New Jersey 08854, USA
    Ann Clin Psychiatry 13:153-8. 2001
  9. ncbi The personality associated with Parkinson's disease
    M Menza
    Department of Psychiatry, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, 675 Hoes Lane, UBHC, Room D207A, Piscataway, NJ 08854, USA
    Curr Psychiatry Rep 2:421-6. 2000
  10. ncbi Modafinil augmentation of antidepressant treatment in depression
    M A Menza
    Department of Psychiatry, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, Piscataway 08854, USA
    J Clin Psychiatry 61:378-81. 2000

Detail Information

Publications26

  1. ncbi The role of inflammatory cytokines in cognition and other non-motor symptoms of Parkinson's disease
    Matthew Menza
    Psychiatry and Neurology, Robert Wood Johnson Medical School, D207A, 671 Hoes Lane, Piscataway, NJ 08854, USA
    Psychosomatics 51:474-9. 2010
    ..However, at present, the pathophysiology and clinical management of these symptoms are poorly understood...
  2. ncbi A controlled trial of antidepressants in patients with Parkinson disease and depression
    M Menza
    Department of Psychiatry, Robert Wood Johnson Medical School, UMDNJ University Behavioral Health Care, Piscataway, NJ 08854, USA
    Neurology 72:886-92. 2009
    ..Depression affects up to 50% of these patients and is associated with a variety of poor outcomes for patients and their families. Despite this, there are few evidence-based data to guide clinical care...
  3. ncbi Managing atypical antipsychotic-associated weight gain: 12-month data on a multimodal weight control program
    Matthew Menza
    Department of Psychiatry, Robert Wood Johnson Medical School, D207A, 671 Hoes Lane, Piscataway, NJ 08854, USA
    J Clin Psychiatry 65:471-7. 2004
    ....
  4. ncbi The impact of treatment of depression on quality of life, disability and relapse in patients with Parkinson's disease
    Matthew Menza
    Department of Psychiatry, Robert Wood Johnson Medical School, Piscataway, New Jersey 08854, USA
    Mov Disord 24:1325-32. 2009
    ....
  5. ncbi Treatment of depression in Parkinson's disease
    Matthew Menza
    Department of Psychiatry, Robert Wood Johnson Medical School, D207A, 671 Hoes Lane, Piscataway, NJ 08854, USA
    Curr Psychiatry Rep 8:234-40. 2006
    ..Randomized controlled trials are needed to evaluate the efficacy of interventional approaches for dPD; several trials are currently underway...
  6. ncbi Residual symptoms in depression: can treatment be symptom-specific?
    Matthew Menza
    Department of Psychiatry, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, Piscataway 08854, USA
    J Clin Psychiatry 64:516-23. 2003
    ..To some extent, this lack of attention reflects an uncertainty in the field about the relationship of the syndrome of depression to the symptoms by which the syndrome is defined...
  7. ncbi Sleep disturbances in Parkinson's disease
    Matthew Menza
    Department of Psychiatry, Robert Wood Johnson Medical School, Piscataway, New Jersey 08854, USA
    Mov Disord 25:S117-22. 2010
    ..Important principles include, diagnosis, treating the specific sleep disorder or co-occurring disorder, and control of the motor aspects of PD...
  8. ncbi Treatment of somatization disorder with nefazodone: a prospective, open-label study
    M Menza
    Department of Psychiatry, Robert Wood Johnson Medical School, Piscataway, New Jersey 08854, USA
    Ann Clin Psychiatry 13:153-8. 2001
    ....
  9. ncbi The personality associated with Parkinson's disease
    M Menza
    Department of Psychiatry, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, 675 Hoes Lane, UBHC, Room D207A, Piscataway, NJ 08854, USA
    Curr Psychiatry Rep 2:421-6. 2000
    ..An integrating hypothesis, involving damage to dopaminergic systems, known to predate the onset of the motor illness, is discussed...
  10. ncbi Modafinil augmentation of antidepressant treatment in depression
    M A Menza
    Department of Psychiatry, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, Piscataway 08854, USA
    J Clin Psychiatry 61:378-81. 2000
    ....
  11. ncbi Treatment of insomnia in Parkinson's disease: a controlled trial of eszopiclone and placebo
    Matthew Menza
    Department of Psychiatry, Robert Wood Johnson Medical School, Piscataway, New Jersey 08854, USA
    Mov Disord 25:1708-14. 2010
    ..Definitive trials of the treatment of sleep disorders in this population are warranted...
  12. ncbi Treatment of erectile dysfunction in men with depressive symptoms: results of a placebo-controlled trial with sildenafil citrate
    S N Seidman
    Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA
    Am J Psychiatry 158:1623-30. 2001
    ....
  13. ncbi Association of a serotonin transporter gene promoter polymorphism with harm avoidance behaviour in an elderly population
    M H Ricketts
    Department of Psychiatry, University of Medicine and Dentistry of New Jersey, Piscataway 08854, USA
    Psychiatr Genet 8:41-4. 1998
    ..Based on these findings it is suggested that there may be increased influence of the 5-HTTLPR short allele on anxiety-related traits during aging...
  14. ncbi Association of long variants of the dopamine D4 receptor exon 3 repeat polymorphism with Parkinson's disease
    M H Ricketts
    Department of Psychiatry, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, Piscataway 08854, USA
    Clin Genet 54:33-8. 1998
    ..039). This provides evidence that some forms of the highly polymorphic D4DR may represent a genetic susceptibility factor for PD...
  15. ncbi Quality of life, mood, and sexual function: a path analytic model of treatment effects in men with erectile dysfunction and depressive symptoms
    R C Rosen
    University of Medicine and Dentistry, Robert Wood Johnson Medical School, Piscataway, New Jersey 08554 5653, USA
    Int J Impot Res 16:334-40. 2004
    ..These data suggest that QoL changes associated with ED therapy may be mediated by changes in sexual function, mood, and family relationships...
  16. ncbi Depression and sexual functioning in minority women: current status and future directions
    Roseanne DeFronzo Dobkin
    Department of Psychiatry, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, Piscataway, 08855, USA
    J Sex Marital Ther 32:23-36. 2006
    ..Further research emphasizing gender and culture is needed to elucidate the prevalence, impact, and treatment of sexual dysfunction in specific groups of depressed minority women...
  17. ncbi Treatment of drug dependence in the context of traditional disease treatment models
    Jeffrey C Merrill
    Robert Wood Johnson Medical School, 671 Hoes Lane, Piscataway, NJ 08854, USA
    Psychiatr Serv 53:1632-3. 2002
  18. ncbi A program for managing weight gain associated with atypical antipsychotics
    Betty Vreeland
    Department of Psychiatry Robert Wood Johnson Medical School and University Behavioral Health Care, University of Medicine and Dentistry of New Jersey, Piscataway, 08855, USA
    Psychiatr Serv 54:1155-7. 2003
    ..These data suggest that the intervention was effective in this group of patients. Professionals treating persons who are taking atypical antipsychotics should encourage them to engage in weight control activities...
  19. ncbi Citalopram treatment of depression in Parkinson's disease: the impact on anxiety, disability, and cognition
    Matthew Menza
    Department of Psychiatry, Robert Wood Johnson Medical School, Camden, New Jersey, USA
    J Neuropsychiatry Clin Neurosci 16:315-9. 2004
    ..As with all nonrandomized, open-label trials at tertiary research centers, many nonspecific factors may have influenced the results...
  20. ncbi CBT for the treatment of depression in Parkinson's disease: a promising nonpharmacological approach
    Roseanne DeFronzo Dobkin
    Department of Psychiatry, UMDNJ Robert Wood Johnson Medical School, 675 Hoes Lane, Room D 317, Piscataway, NJ 08854, USA
    Expert Rev Neurother 8:27-35. 2008
    ..In order to be most effective for PD patients, CBT should be tailored to their unique needs. Additional controlled research is needed to further explore the efficacy of CBT for dPD...
  21. ncbi Trazodone and ejaculatory inhibition
    Kenneth R Kaufman
    Department of Psychiatry, UMDNJ Robert Wood Johnson Medical School, New Brunswick, NJ 08901, USA
    J Sex Marital Ther 33:225-30. 2007
    ....
  22. ncbi Cognitive-behavioral therapy for depression in Parkinson's disease: a pilot study
    Roseanne DeFronzo Dobkin
    Department of Psychiatry, UMDNJ Robert Wood Johnson Medical School, Piscataway, New Jersey 08854, USA
    Mov Disord 22:946-52. 2007
    ..Larger, randomized controlled trials are needed to further evaluate the efficacy of this intervention and to identify specific mechanisms of change...
  23. ncbi Efficacy of the team solutions program for educating patients about illness management and treatment
    Betty Vreeland
    University Behavioral HealthCare UBHC and Robert Wood Johnson Medical School of the University of Medicine and Dentistry of New Jersey UMDNJ, Piscataway, New Jersey 08855, USA
    Psychiatr Serv 57:822-8. 2006
    ..Team Solutions was chosen for study because it is available over the Internet and other venues at no cost and is used by mental health agencies across the United States and Canada...
  24. ncbi A cognitive-behavioral treatment package for depression in Parkinson's disease
    Roseanne DeFronzo Dobkin
    Department of Psychiatry, UMDNJ-Robert Wood Johnson Medical School, 675 Hoes Lane, Rm. D-317, Piscataway NJ 08855, USA
    Psychosomatics 47:259-63. 2006
  25. ncbi Bupropion improves sexual functioning in depressed minority women: an open-label switch study
    Roseanne DeFronzo Dobkin
    University of Medicine and Dentistry of New Jersey Robert Wood Johnson Medical School, Department of Psychiatry, Piscataway, NJ 08855, USA
    J Clin Psychopharmacol 26:21-6. 2006
    ..The majority of women successfully completed the trial and planned to continue using bupropion SR after their participation in the study...
  26. ncbi STAR*D: the results begin to roll in
    Matthew Menza
    Am J Psychiatry 163:1123. 2006